Report overview
The global Vascular Embolization Agent market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Temporary Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Vascular Embolization Agent include Abbott, Boston Scientific Corporation, Cook Medical LLC, Johnson & Johnson, Medtronic, Acandis GmbH, SSEM Mthembu Medical (Pty) Ltd, Balt USA LLC and Stryker, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Vascular Embolization Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vascular Embolization Agent. This report contains market size and forecasts of Vascular Embolization Agent in global, including the following market information:
Global Vascular Embolization Agent Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Vascular Embolization Agent Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Vascular Embolization Agent companies in 2023 (%)
We surveyed the Vascular Embolization Agent manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Vascular Embolization Agent Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Vascular Embolization Agent Market Segment Percentages, by Type, 2023 (%)
Temporary
Permanent
Global Vascular Embolization Agent Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Vascular Embolization Agent Market Segment Percentages, by Application, 2023 (%)
Hospital
Ambulatory Surgery Center
Global Vascular Embolization Agent Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Vascular Embolization Agent Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Vascular Embolization Agent revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Vascular Embolization Agent revenues share in global market, 2023 (%)
Key companies Vascular Embolization Agent sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Vascular Embolization Agent sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Boston Scientific Corporation
Cook Medical LLC
Johnson & Johnson
Medtronic
Acandis GmbH
SSEM Mthembu Medical (Pty) Ltd
Balt USA LLC
Stryker
Guerbet LLC
Terumo Corporation
Penumbra
Grandpharma (Sirtex)
Merit Medical
Siemens Healthineers (Varian)
Jiangsu Hengrui Medicine
Kaneka
Meril Life Sciences
Peijia Medical
Wallaby Medical
MicroPort Scientific Corporation
Weihai Visee Medical Devices
Beijing Taijieweiye Technology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Vascular Embolization Agent, market overview.
Chapter 2: Global Vascular Embolization Agent market size in revenue and volume.
Chapter 3: Detailed analysis of Vascular Embolization Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Vascular Embolization Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Vascular Embolization Agent capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
